Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results

4/28/25 7:47:00 AM ET

Industrial Specialties

Health Care

Get the next $AVNS alert in real time by email

ALPHARETTA, Ga., April 28, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2025 on Tuesday, May 6 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.

The conference call will be hosted by Dave Pacitti, chief executive officer, Jason Pickett, interim chief financial officer, Scott Galovan, senior vice president, strategy and corporate development, and Gary Blackford, Avanos board chairman.

To instantly join the conference call by phone, use the following link to register close to the call start time: https://emportal.ink/4gbW8ah. After registering, the system will call you and automatically connect you to the conference call. Alternatively, you may join the call by dialing 1-646-357-8785 or 1-800-836-8184 and you will be connected to the call by an operator.

A simultaneous webcast of the call and the related presentation will be accessible via the Investors section of the Avanos Medical website, https://avanos.investorroom.com/. The replay will be accessible within two hours of the end of the call and will be available for one week. Alternatively, you may dial 1-646-517-4150 or 1-888-660-6345 and enter passcode 22122 #.

About Avanos Medical, Inc.

Avanos Medical (NYSE:AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures, and markets its recognized brands globally and holds leading market positions in multiple product categories. For more information, visit www.avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn and Facebook.

View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-webcast-conference-call-discussing-first-quarter-2025-financial-results-302439633.html

SOURCE Avanos Medical

Get the next $AVNS alert in real time by email

Recent Analyst Ratings for

$AVNS

Date	Price Target	Rating	Analyst
7/25/2023		Overweight → Sector Weight	KeyBanc Capital Markets
5/22/2023	$31.00	Buy	CL King
2/24/2022	$47.00 → $41.00	Overweight	Keybanc
1/7/2022	$37.00 → $36.00	Underweight	Morgan Stanley
8/4/2021	$45.00 → $41.00	Underweight	Morgan Stanley
8/4/2021	$60.00 → $45.00	Overweight → Equal-Weight	Stephens
8/4/2021	$55.00 → $47.00	Overweight	Keybanc

More analyst ratings

Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results

Chat with this insight

Recent Analyst Ratings for
$AVNS

$AVNS
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Shimer Julie Ann bought $9,925 worth of shares (500 units at $19.85), increasing direct ownership by 1% to 50,090 units (SEC Form 4)

$AVNS
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Former Interim CEO Greiner Michael covered exercise/tax liability with 24,245 shares, decreasing direct ownership by 11% to 200,019 units (SEC Form 4)

New insider Pickett Jason Marc claimed ownership of 40,113 shares (SEC Form 3)

Amendment: New insider Pacitti David claimed ownership of 242,047 shares (SEC Form 3)

$AVNS
Financials

Live finance-specific insights

Avanos Medical, Inc. Announces First Quarter 2025 Results